When regulators and manufacturers work from the same intelligence, friction falls on both sides.
Explore the HERMS approach and our solutions portfolio.
Government and private life sciences organisations often experience the same process from opposite sides. A submission that is unclear for the manufacturer is slow to evaluate for the regulator.
HERMS applications are designed around real regional practice on both sides. Regulators gain consistent, traceable rule interpretation and evidence-based tender evaluation. Health authorities gain earlier detection of patient-safety signals.
Manufacturers and market authorisation holders gain submission-ready preparation, promotional material checked against local rules, pricing evidence built for payers, and supply continuity with quality integrity.
Both sides work from the same governed intelligence. The model proposes, the rules engine decides, and the audit trail records both.
Shared standards reduce friction for everyone in the ecosystem.